Study Evaluating AGG-523 in Subjects With Osteoarthritis
NCT00427687
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Osteoarthritis
Interventions
DRUG:
AGG-523
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer